Hospital of the University of Occupational and Environmental Health, Japan
Kitakyushu-shi, Hukuoka 807-8556
2 studies enrolling now · 5 studies all time
What they study most
Immunoglobulin A (IgA) Nephropathy, Immunoglobulin A Nephropathy (IgAN), Sjogren's Syndrome, Sjögren's Syndrome, Sjögren's Syndrome (SS)
Studies at this site
- A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) — Recruiting now
- A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) — Recruiting now
- Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy — Completed
- A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity — Running, not enrolling
- A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State — Running, not enrolling